Laura G. Hansen
Investor Relations Contact presso DENALI THERAPEUTICS INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ryan Watts | M | 48 | 11 anni | |
| James Schoeneck | M | 66 | 14 anni | |
| Marc Tessier-Lavigne | M | 64 | 11 anni | |
| Alexander Schuth | M | 50 | 11 anni | |
| Steve Krognes | M | 56 | 9 anni | |
| Vicki Sato | M | 75 | 9 anni | |
| Jennifer Cook | F | 58 | 6 anni | |
| Nancy Thornberry | F | 67 | 3 anni | |
| Peter Klein | M | 61 | 6 anni | |
| Jay Flatley | M | 71 | 9 anni | |
| Meichiel Keenan | F | - | 20 anni | |
| David Schenkein | M | 66 | 9 anni | |
| Erik Harris | M | 54 | 2 anni | |
| Michael D. Lowenstein | M | - | 21 anni | |
| Brian E. Chee | M | 57 |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 5 anni |
| Carole Ho | M | 51 | 9 anni | |
| Cindy Dunkle | F | - | - | |
| Christine Chung L. | F | 56 | 17 anni | |
| Julie Sunderland | F | 51 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 5 anni |
| Dana Andersen | M | - | 6 anni | |
| Chris Walsh | M | - | - | |
| Erica Kratz | F | - | - | |
| Joe Lewcock | M | - | 4 anni | |
| Katie Peng | F | - | 3 anni | |
| Lori Hu | F | 38 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 5 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Stephen Dilly | M | 64 | 4 anni | |
| Jayson Dallas | M | 56 | 2 anni | |
| Andrew Oxtoby | M | 50 | - | |
| Douglas T. Sheehy | M | 57 | 4 anni | |
| Brett K. Haumann | M | 54 | - | |
| Roberto Pedro Rosenkranz | M | 74 | 10 anni | |
| Toshinari Tamura | M | 80 | 12 anni | |
| Joseph Suttner | M | - | - | |
| Grégory Behar | M | 55 | 4 anni | |
| Warren L. DeSouza | M | 55 | 2 anni | |
| Brain Roberts | M | 49 | 5 anni | |
| Mark Hopkins | M | - |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | - |
| Hong He | M | 55 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | - |
| Michael Martinelli | M | - | 11 anni | |
| Annette Marcantonio | F | - | 4 anni | |
| Brian Vickery | M | - | - | |
| Seth Porter | M | - | 13 anni | |
| Sriram Ryali | M | 43 | 3 anni | |
| Jane Tiller | M | 59 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 1 anni |
| Gerd Kochendoerfer | M | 56 | 3 anni | |
| Jeffrey H. Knapp | M | 58 | 2 anni | |
| Paul J. Frohna | M | - | 1 anni | |
| Matthew Fust | M | 59 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 3 anni |
| Kenneth F. Boehm | M | - | 3 anni | |
| Frank Valone | M | 74 | 8 anni | |
| Eric Bjerkholt | M | 64 | 3 anni | |
| Kristina Burow | F | 50 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 7 anni |
| Daniel Adelman | M | 66 | 5 anni | |
| David Y. Liu | M | 73 | 8 anni | |
| Asish Xavier | M | - |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 5 anni |
| Christopher J. Molineaux | M | 70 | 4 anni | |
| R. Wayne Frost | M | 69 | - | |
| Claire J. Lockey | F | 71 | 7 anni | |
| Grace U. Shin | F | 59 | 9 anni | |
| Nipun Davar | M | - |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 4 anni |
| Sarah O'Dowd | F | 74 | 1 anni | |
| Kin Hung Yu | M | 61 | 12 anni | |
| Russell Ellison | M | 76 | 2 anni | |
| Julianne Averill | F | 39 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 64 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Laura G. Hansen
- Contatti personali
